Unknown

Dataset Information

High-Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease.


ABSTRACT:

Background

The relative benefit of higher statin dosing in patients with peripheral artery disease has not been reported previously. We compared the effectiveness of low- or moderate-intensity (LMI) versus high-intensity (HI) statin dose on clinical outcomes in patients with peripheral artery disease.

Methods and results

We reviewed patients with symptomatic peripheral artery disease who underwent peripheral angiography and/or endovascular intervention from 2006 to 2013 who were not taking other lipid-lowering medications. HI statin use was defined as atorvastatin 40-80 mg or rosuvastatin 20-40 mg. Baseline demographics, procedural data, and outcomes were retrospectively analyzed. Among 909 patients, 629 (69%) were prescribed statins, and 124 (13.6%) were treated with HI sta

SUBMITTER: Foley TR 

PROVIDER: S-EPMC5586293 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature